Pulmonx Corp
(FRA:4NI)
€
1.76
+0.080 (+4.79%)
Market Cap: 85.11 Mil
Enterprise Value: 85.43 Mil
PE Ratio: 0
PB Ratio: 2.51
GF Score: 62/100 Pulmonx Corp at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Sep 13, 2021 / 08:15PM GMT
Release Date Price:
€33.4
(-1.76%)
Cecilia E. Furlong
Morgan Stanley, Research Division - Equity Analyst
Good afternoon, and thank you for joining us for the third day of the 2021 Morgan Stanley Healthcare Conference. I'm Cecilia Furlong, medical device analyst and a member of the health care research team here at Morgan Stanley. It's my pleasure to have Pulmonx with us today, Glen French, President and CEO; and Derrick Sung, CFO.
And before we begin, I'll run through our disclaimer. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.
And with that, Glen, Derrick, thank you both for joining us today.
Glendon E. French
Pulmonx Corporation - CEO, President & Director
Thank you.
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot